MD2 Biosciences Inc is a biopharmaceutical company based in San Diego, CA, specializing in oncology drug discovery and development. With a focus on addressing high unmet needs in oncology and pulmonary fibrosis, the company utilizes artificial intelligence (AI) in their drug discovery and optimization process, employing a novel platform to identify small-molecule hits suitable for flat proteins and generating novel lead compounds with suitable properties for administration and blood-brain barrier penetration.
Committed to enhancing and extending the lives of patients suffering from various cancers, MD2 Biosciences Inc brings together a team of experienced scientists, key opinion leaders, and industry experts to drive their mission forward. Through their scientific expertise and AI capabilities, the company aims to develop best-in-class or first-in-class programs that target specific oncogenic proteins, ultimately advancing cancer therapy and improving patient outcomes.
Generated from the website